Literature DB >> 18078741

Fibroblasts from non-healing human chronic wounds show decreased expression of beta ig-h3, a TGF-beta inducible protein.

Jisun Cha1, Taehee Kwak, Janet Butmarc, Tae-Aug Kim, Tatyana Yufit, Polly Carson, Seong-Jin Kim, Vincent Falanga.   

Abstract

BACKGROUND: Increasing evidence shows persistent phenotypic alterations in fibroblasts from non-healing human chronic wounds, which may result in faulty extracellular matrix deposition and keratinocyte migration. We have previously shown that these cells are characterized by morphological changes, low proliferative potential and unresponsiveness to TGF-beta1, and down regulated phosphorylation of Smad 2/3 and p42/44 MAPK from decreased expression of the TGF-beta type II receptor.
OBJECTIVE: To identify genes and proteins that may be differentially expressed in chronic wounds and their cultured fibroblasts.
METHODS: Differential display analysis with 120 random primer sets was used in fibroblasts from human venous ulcers and acute wounds created on the ipsilateral thighs of the same patients. Positive differential results were confirmed by RT-PCR. Immunohistochemistry of cultured fibroblasts and tissues was used to determine the expression of differentially expressed proteins.
RESULTS: A total of 16 differentially expressed genes were identified and cloned. The only candidate gene that was differentially expressed in all patients and confirmed by repeated differential display testing and RT-PCR was beta ig-h3, a TGF-beta-induced gene involved in cell adhesion, migration, and proliferation. Decreased expression of beta ig-h3 in chronic wounds and their fibroblasts was further confirmed by Western blot and immunostaining.
CONCLUSION: These findings point to beta ig-h3 as an important gene characterizing the abnormal phenotype of chronic wound fibroblasts. Corrective measures to increase the expression of this protein might have therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078741     DOI: 10.1016/j.jdermsci.2007.10.010

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  5 in total

1.  Potential of oncostatin M to accelerate diabetic wound healing.

Authors:  Soo Hye Shin; Seung-Kyu Han; Seong-Ho Jeong; Woo-Kyung Kim
Journal:  Int Wound J       Date:  2012-11-01       Impact factor: 3.315

2.  Oral administration of skin gelatin isolated from Chum salmon (Oncorhynchus keta) enhances wound healing in diabetic rats.

Authors:  Zhaofeng Zhang; Ming Zhao; Junbo Wang; Ye Ding; Xiaoqian Dai; Yong Li
Journal:  Mar Drugs       Date:  2011-04-26       Impact factor: 6.085

3.  Platelet-Released Growth Factors and Platelet-Rich Fibrin Induce Expression of Factors Involved in Extracellular Matrix Organization in Human Keratinocytes

Authors:  Andreas Bayer; Bernard Wijaya; Lena Möbus; Franziska Rademacher; Meno Rodewald; Mersedeh Tohidnezhad; Thomas Pufe; Daniel Drücke; Regine Gläser; Jürgen Harder
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

4.  Platelet-rich plasma and platelet-derived lipid factors induce different and similar gene expression responses for selected genes related to wound healing in rat dermal wound environment.

Authors:  Fahri Akbas; Busra Ozdemir; Nurten Bahtiyar; Hulya Arkan; Ilhan Onaran
Journal:  Mol Biol Res Commun       Date:  2020-12

5.  Identification and Characterization of Novel Matrix-Derived Bioactive Peptides: A Role for Collagenase from Santyl® Ointment in Post-Debridement Wound Healing?

Authors:  Anthony R Sheets; Tatiana N Demidova-Rice; Lei Shi; Vincent Ronfard; Komel V Grover; Ira M Herman
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.